Table 2.
Experimental models | Targets | Effects | Reference |
---|---|---|---|
TAC SD rabbits | EF, FS↑, LVESD↓, LVEDD↓, LVESV↓, LVEDV↓, TDR↓, VFT↑ | Anti-arrhythmia and improving cardiac structure | Liu et al., 2012 |
TAC SD rabbits | SACT↓ | Anti-arrhythmia | Liu et al., 2011 |
MI and depressed SD rats | MAPD90↓, Left ventricular-ERP↓, VFT↑ | Improving cardiac electrical remodeling | Liang et al., 2012 |
I/R SPF rats | Incidence of VT+ VF↓, duration of VT +VF↓, CK↓, CK-MB↓, LDH↓, AST↓ | Anti-arrhythmia and protecting myocardium | Jin et al., 2006 |
I/R SPF rats | Na+-K+-ATPase↑, Ca2+ ATPase↑, Mg2+ ATPase↑, ST segment elevation(MAX)↓ | Anti-arrhythmia and improving of myocardial ischemia | Zeng et al., 2006 |
BL-induced SD rats I/R SD rats | Incidence of VT +VF↓, Duration of arrhythmia↓; Degree of ST segment elevation↓ | Inhibiting BL-reduced arrhythmia and protecting myocardium | Guo et al., 2013 |
ISO-induced SD rats | MDP↓, APA↓, PRF↓, VDD↓, Vmax↓, APD90↑ | Reducing spontaneous discharge frequency and anti-arrhythmia | Xu et al., 2010 |
Ischemia-induced rats; Cardiac ventricular myocytes | Incidence of VT +VF↓, Number of episodes of VT+VF↓, number of episodes of VEBs/min↓, arrhythmia score↓, ICaL↓, Ito↓, | Attenuating ischemia-induced ventricular arrhythmias | Wang et al., 2013 |
Guinea pig hearts | HR↑, QRS↓, Q-T interval↓, CaV 1.2 channel↓ | Prevention of quinidine-induced arrhythmia | Wang et al., 2017 |
Rabbit Purkinje cells | APD↓, EADs↓, DADs↓, TAs↓, INaL↓, INaP↓, ICaL↓ | Exhibiting antiarrhythmic role via selective inhibition of INaL | Hou et al., 2016 |
Rats ventricular myocytes | APD↓, ICaL↓ | Treatment of arrhythmias | Chen et al., 2013a |
Rats ventricular myocytes | ICa↓, I–V curve↑ | Anti-arrhythmia | Wang et al., 2011b |
Rats ventricular myocytes | Ito↓, I–V curve↓ | Anti-arrhythmia | Wang et al., 2010 |
Rabbit ventricular myocytes | INaL↓, INCX↓, ICaL↓, APD↓ | Inhibiting hypoxia-reoxygenation induced tachycardia | Luo et al., 2017 |
Rabbit ventricular myocytes | INaL↓, EADs↓, DADs↓, Q-T interval↓ | Inhibiting ventricular arrhythmias | Xue et al., 2013 |
Rabbits ventricular myocytes | APD90↑, TDR↓ | Anti-arrhythmia | Cui, 2007 |
Canine cardiomyocytes | P2R↓, VT↓, VF↓, NMI↓, J Wave Area↓, Ito↓, ICa↓ | Suppressed arrhythmogenesis of Brugada syndrome | Minoura et al., 2013 |
Canine atrial and ventricular myocytes, HEK293 Cells | Atrial-selective Na+ channels↓ | Suppression of atrial fibrillation | Hu et al., 2016 |
Canine arterially perfused right atrial preparations with a rim of right ventricular tissue; HEK293 cells | APD90↓, Atrial-selective ERP↑, INa↓ | Suppressed atrial fibrillation | Burashnikov et al., 2012 |
Ouabain-perfused ventricular myocytes | APD90↑, EAD↓, TA↓ | Anti-arrhythmia | Chen et al., 2010 |
Xenopus oocyte | HCN2 instantaneous currency↑ | Regulation of HCN2 channel | Li et al., 2011 |
INCX, Na+–Ca2+ exchange current; INaP, peak sodium current; GP, ganglionic plexi; VEB, ventricular ectopic beats; Ito, transient outward potassium current; P2R, phase 2 re-entry; NMI, notch magnitude index; ERP, effective refractory period; BL, barium chloride; MAP, monophasic action potential; VFT, ventricular fibrillation threshold; I–V, current–voltage; TDR, transmural repolarization dispersion; HCN2, hyperpolarization-activated cyclic nucleotide-gated cation channels-2.